The ONCO/Reveal Myeloid Panel is a robust NGS assay that interrogates 58 genes of interest* most relevant to myeloid cancer. The panel uses proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology for efficient single-tube target enrichment.
- Requires as little as 10 ng of input DNA
- Detection of 1% allele frequency in somatic cancers
- Single sample / single well assay technology for enhanced sensitivity
- Automatable sample processing